Derivation of New Human Embryonic Stem Cell Lines: Identification of Instructive Factors for Germ Cells Development
The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by Soroka University Medical Center.
Recruitment status was Not yet recruiting
Recruitment status was Not yet recruiting
Sponsor:
Soroka University Medical Center
Collaborator:
Ben-Gurion University of the Negev
Information provided by:
Soroka University Medical Center
ClinicalTrials.gov Identifier:
NCT01165918
First received: July 6, 2010
Last updated: July 18, 2010
Last verified: June 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is
- To generate human embryonic stem cells lines (hESC) lines
- Study of the factors that contribute to differentiation towards germ cell.
| Condition |
|---|
|
Normal Healthy Embryos |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Basic Research. Unveiling Factors That Contribute to Germ Cell Differentiation |
Further study details as provided by Soroka University Medical Center:
Primary Outcome Measures:
- New hESC [ Time Frame: 1 year ] [ Designated as safety issue: No ]Donated embryos will be used for derivation of the Es cells
Secondary Outcome Measures:
- Factors that contribute to germ cells differentiation [ Time Frame: 4 years ] [ Designated as safety issue: No ]We shall employ the knowledge from a study of sperm differentiation in mice to instruct the differentiation of ES cells towards germ cells
| Estimated Enrollment: | 50 |
| Study Start Date: | October 2010 |
| Groups/Cohorts |
|---|
| Donated embryos |
Eligibility| Ages Eligible for Study: | up to 4 Days |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
any donated embryo
Criteria
Inclusion Criteria:
- any donated embryos
Exclusion Criteria:
- not relevant
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01165918
Contacts
| Contact: Eitan Lunenfeld, MD and Prof. | - 972-8-6460058 | lunenfld@bgumail.bgu.ac.il |
| Contact: Rivka Ofir | 97286477272 | rivir@bgu.ac.il |
Locations
| Israel | |
| Soroka medical center | Not yet recruiting |
| Beer Sheva, Israel, 84101 | |
| Contact: Rivka Ofir, PhD 972 8 6477272 rivir@bgu.ac.il | |
| Sub-Investigator: Rivka Ofir, PhD | |
Sponsors and Collaborators
Soroka University Medical Center
Ben-Gurion University of the Negev
More Information
No publications provided
| Responsible Party: | Dr. Eitan Lunenfeld, Soroka Medical Center |
| ClinicalTrials.gov Identifier: | NCT01165918 History of Changes |
| Other Study ID Numbers: | Sor491210CTIL |
| Study First Received: | July 6, 2010 |
| Last Updated: | July 18, 2010 |
| Health Authority: | Israel:Clalit Health Service |
ClinicalTrials.gov processed this record on June 13, 2013